학술논문
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
Document Type
Article
Author
Mato, A.R. ; Hill, B.T.; Lamanna, N.; Barr, P.M.; Ujjani, C.S.; Brander, D.M.; Howlett, C.; Skarbnik, A.P.; Cheson, B.D.; Zent, C.S.; Pu, J.J.; Kiselev, P.; Foon, K.; Lenhart, J.; Henick Bachow, S.; Winter, A.M.; Cruz, A.-L.; Claxton, D.F.; Goy, A.; Daniel, C.; Isaac, K.; Kennard, K.H.; Timlin, C.; Fanning, M.; Gashonia, L.; Yacur, M.; Svoboda, J.; Schuster, S.J.; Nabhan, C.
Source
In Annals of Oncology May 2017 28(5):1050-1056
Subject
Language
ISSN
0923-7534